Gold vs US Dollar

Register to chat with like-minded investors on our interactive forums.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Werewolf Therapeutics Inc (HOWL)
Werewolf Therapeutics Inc (HOWL) Financials

HOWL Werewolf Therapeutics Inc

3.555

0.055 (1.57%)

Last Updated: 20:36:56

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-168.172	-47.794	-146.509	-31.7	-22.304
Return on Equity (%)	150.008	74.092	-400.153	-39.117	-31.978
Return on Invested Capital (%)	-207.844	-45.528	-41.776	-41.42	-33.452
Operating Margin (%)	N/A	N/A	N/A	-328.09	-171.634
Net Profit Margin (%)	N/A	N/A	N/A	-328.09	-187.374
Book Value Per Share	0.649	5.894	5.594	3.892	3.077
Earnings Per Share	-1.211	-1.864	-7.393	-1.712	-1.032
Cash Per Share	1.189	6.115	5.768	4.114	3.712
Working Capital Per Share	1.064	5.789	5.462	3.697	3.288
Operating Profit Per Share	N/A	N/A	N/A	0.522	0.551
EBIT Per Share	-0.681	-0.994	-1.83	-1.712	-1.032
EBITDA Per Share	-0.681	-0.994	-1.83	-1.712	-1.032
Free Cash Flow Per Share	-1.195	-1.837	-7.383	-1.632	-1.06

Liquidity Ratios

Year End 31 December 2023	2019	2020	2021	2022	2023
Current Ratio	8.837	17.584	13.565	5.844	7.141
Quick Ratio	8.755	17.519	13.267	5.391	6.944
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	15.06M	15.14M	27.31M	31.43M	N/A

Key Stats and Ratios

Year End 31 December 2023	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	28.28M	30.61M	31.43M	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	-268.414	N/A	N/A	N/A	-2047.17
Net Profit Margin (%)	N/A	N/A	N/A	-268.414	N/A	N/A	N/A	-2182.345
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	7.208	N/A	N/A	N/A	6.707
Quick Ratio	N/A	N/A	N/A	6.817	N/A	N/A	N/A	6.571
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	151.72M
Price to Earnings Ratio	-4.06
Price to Sales Ratio	7.61
Price to Cash Ratio	1.13
Price to Book Ratio	1.36
Dividend Yield	-

Share Statistics

Shares Outstanding	42.74M
Average Volume (1 week)	293.7k
Average Volume (1 Month)	198.33k
52 Week Change	-1.25%
52 Week High	8.1939
52 Week Low	1.5735

More Ratios Coming Soon!

Werewolf Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions